# EDGAR Filing Document

**Accession Number:** 0001555280
**File Stem:** 0001193125-25-178082
**Filing Date:** 2025-8
**Character Count:** 6362
**Document Hash:** d419d291d59440d5c8b5d29d34b80c1e
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-25-178082.hdr.sgml**: 20250811

**ACCESSION NUMBER**: 0001193125-25-178082

**CONFORMED SUBMISSION TYPE**: FWP

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20250811

**DATE AS OF CHANGE**: 20250811

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Zoetis Inc.
- **CENTRAL INDEX KEY:** 0001555280
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 460696167
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** FWP
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 333-289241
- **FILM NUMBER:** 251203039

**BUSINESS ADDRESS:**
- **STREET 1:** 10 SYLVAN WAY
- **CITY:** PARSIPPANY
- **STATE:** NJ
- **ZIP:** 07054
- **BUSINESS PHONE:** 973-822-7000

**MAIL ADDRESS:**
- **STREET 1:** 10 SYLVAN WAY
- **CITY:** PARSIPPANY
- **STATE:** NJ
- **ZIP:** 07054
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Zoetis Inc.
- **CENTRAL INDEX KEY:** 0001555280
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 460696167
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** FWP

**BUSINESS ADDRESS:**
- **STREET 1:** 10 SYLVAN WAY
- **CITY:** PARSIPPANY
- **STATE:** NJ
- **ZIP:** 07054
- **BUSINESS PHONE:** 973-822-7000

**MAIL ADDRESS:**
- **STREET 1:** 10 SYLVAN WAY
- **CITY:** PARSIPPANY
- **STATE:** NJ
- **ZIP:** 07054

**Issuer Free Writing Prospectus** 

**Filed Pursuant to Rule 433** 

**Registration Statement No. 333-289241** 

**Supplementing the Preliminary** 

**Prospectus Supplement dated August 11, 2025** 

**(To Prospectus dated August 5, 2025)** 

**Pricing Term Sheet** 

**$1,850,000,000**![LOGO](g60631g0812015344699.jpg)

**Zoetis Inc.** 

**August 11, 2025** 

**$850,000,000 4.150% Senior Notes due 2028** 

**$1,000,000,000 5.000% Senior Notes due 2035** 

---

| | | |
|:---|:---|:---|
| Issuer: | Zoetis Inc. |  |
| Principal Amount: | $850000000 | $1000000000 |
| Maturity Date: | August 17, 2028 | August 17, 2035 |
| Interest Payment Dates: | February 17 and August 17, commencing February 17, 2026 | February 17 and August 17, commencing February 17, 2026 |
| Coupon: | 4.150% | 5.000% |
| Benchmark Treasury: | 3.625% UST due August 15, 2028 | 4.250% UST due August 15, 2035 |
| Benchmark Treasury Price and Yield: | 99-22 <sup>5</sup>⁄<sub>8</sub> / 3.729% | 99-26 / 4.273% |
| Spread to Benchmark Treasury: | +45 bps | +75 bps |
| Price to Public: | 99.919% of the principal amount | 99.821% of the principal amount |
| Yield to Maturity: | 4.179% | 5.023% |
| Make-Whole Redemption: | +10 bps | +15 bps |
| Par Call: | On or after July 17, 2028 (one month before maturity) | On or after May 17, 2035 (three months before maturity) |
| CUSIP/ISIN: | 98978V AW3 / US98978VAW37 | 98978V AX1 / US98978VAX10 |
| Denominations: | $2,000 and integral multiples of $1,000 |  |
| Expected Ratings of the Notes\*: | A3 / BBB+ (Moody's /S&P) |  |
| Trade Date: | August 11, 2025 |  |

---

------

---

| | |
|:---|:---|
| Settlement Date\*\*: | August 18, 2025 (T+5) |
| Joint Book-Running Managers: | Barclays Capital Inc.<br> BofA Securities, Inc.<br> Citigroup Global Markets Inc.<br> J.P. Morgan Securities LLC<br> MUFG Securities Americas Inc.<br> BBVA Securities Inc.<br> BNP Paribas Securities Corp.<br> Goldman Sachs & Co. LLC<br> HSBC Securities (USA) Inc.<br> Rabo Securities USA, Inc.<br> Standard Chartered Bank<br> TD Securities (USA) LLC |
| Senior Co-Managers: | ING Financial Markets LLC |
| Co-Managers: | Loop Capital Markets LLC<br> Academy Securities, Inc.<br> R. Seelaus & Co., LLC<br> Samuel A. Ramirez & Company, Inc. |

---

**\*** **An explanation of the significance of ratings may be obtained from the ratings agencies. Generally, ratings agencies base their ratings on such material and information, and such of their own investigations, studies and assumptions, as they deem appropriate. The security ratings above are not a recommendation to buy, sell or hold the securities offered hereby. The ratings may be subject to review, revision, suspension, reduction or withdrawal at any time by the rating agencies. Each of the security ratings above should be evaluated independently of any other security rating.** 

**\*\*** **We expect to deliver the notes against payment for the notes on August 18, 2025, the fifth business day following the date of this pricing term sheet ("T+5"). Under Rule 15c6-1 of the Exchange Act, trades in the secondary market generally are required to settle in one business day, unless the parties to a trade expressly agree otherwise. Accordingly, purchasers who wish to trade the notes on any date prior to the business day before delivery will be required, by virtue of the fact that the notes initially settle in T+5 on August 5, 2025, to specify an alternative settlement arrangement at the time of any such trade to prevent a failed settlement. Purchasers of the notes who wish to trade the notes prior to the business day preceding the delivery date of the notes should consult their advisors.** 

**The issuer has filed a registration statement (including a prospectus and preliminary prospectus supplement) with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus supplement and accompanying prospectus if you request it by calling Barclays Capital Inc. toll-free at 1-888- 603-5847, BofA Securities, Inc. toll-free at 1-800-294-1322, Citigroup Global Markets Inc. toll-free at 1-800-831-9146, J.P. Morgan Securities LLC collect at 1-212-834-4533, or MUFG Securities Americas Inc. toll-free at 1-877-649-6848.** 

------

**Any disclaimer or other notice that may appear below is not applicable to this communication and should be disregarded. Such disclaimer or notice was automatically generated as result of this communication being sent by Bloomberg or another email system.**